Convergence Investment Partners, LLC Moderna, Inc. Transaction History

Convergence Investment Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$126.46 - $235.05 $139,106 - $258,555	-1,100 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$225.82 - $368.51 $90,779 - $148,141	-402 Reduced 26.76%	1,100 $279,000
Q3 2021 Oct 25, 2021	BUY	$221.9 - $484.47 $30,178 - $65,887	136 Added 9.96%	1,502 $578,000
Q2 2021 Jul 19, 2021	SELL	$129.91 - $234.98 $109,384 - $197,853	-842 Reduced 38.13%	1,366 $321,000
Q1 2021 Apr 30, 2021	BUY	$109.18 - $185.98 $241,069 - $410,643	2,208 New	2,208 $289,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Convergence Investment Partners, LLC with notifications on news.